CLOs on the Move

Colon And Rectal Surgery Associates Ltd

www.colonrectal.org

 
Colon And Rectal Surgery Associates Ltd is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Saint Paul, MN. To find more information about Colon And Rectal Surgery Associates Ltd, please visit www.colonrectal.org
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.colonrectal.org
  • 393 Dunlap St N Ste 500
    Saint Paul, MN USA 55104-4206
  • Phone: 651.312.1500

Executives

Name Title Contact Details

Similar Companies

Health Partners Plans

Health Partners Plans is a health insurance organization serving more than 267,456 members in Southeastern Pennsylvania. Founded more than 30 years ago, Health Partners Plans offers Medicaid, Medicare and Children`s Health Insurance Program (CHIP) plans that include special benefits to improve the health and wellness of our members. We`re also committed to boosting the health of our community through outreach, education and events. Health Partners Plans is one of the few hospital-owned health maintenance organizations in the country. We continually develop new ways to encourage better health outcomes and have received national recognition for our innovations in managed care.

Gladden Longevity

Gladden Longevity is a comprehensive concierge medical program dedicated to health optimization and performance, with a focus on age reversal. They offer wellness and fitness services, neurocognitive testing, body composition analysis, cardiovascular p...

Columbus Regional Healthcare System

Columbus Regional Healthcare System is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Columbus Regional Healthcare System is based in Whiteville, NC. You can find more information on Columbus Regional Healthcare System at www.crhealthcare.org

Keystone Emergency Management Group

Keystone Emergency Management Group is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines. We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines. We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies. Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.